GlassScriptPhysician profile
Ricky C Mehta
NPI 1336569052
$424.37
in general payments reported to CMS, 2019-2025
6 companies · $99.00 in 2025
The $99.00 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $85.24 · 2021: $40.24 · 2022: $28.11 · 2024: $13.58 · 2025: $99.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $99.00 · Food and Beverage: $13.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $99.00 |
| Food and Beverage | $13.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $144.29 | 2019-2022 | |
| Janssen Biotech, INC. | $139.37 | 2020-2025 | Tremfya |
| Portola Pharmaceuticals, LLC | $100.01 | 2019-2020 | |
| Horizon Therapeutics Plc | $14.18 | 2021 | |
| Abbott Laboratories | $13.58 | 2024 | Octrode |
| Medtronic, INC. | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricky Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.